LatestCorporate Compliance 11 September 2026
AGM Extension Guide and Gland Pharma September Investor Meetings
The Tax Corp releases a detailed guide on extending AGM deadlines under Section 96 for FY 2025‑26, outlining compliance steps and calendar dates. Meanwhile, Gland Pharma announces its analyst and institutional investor meetings slated for September 2026, with details on the engagement calendar and key company officials.
- AGM Extensions Guide: The Tax Corp explains how companies can apply for AGM extensions for FY 2025‑26 under Section 96, providing a compliance calendar and required forms. Read more
- Gland Pharma Investor Meetings: Gland Pharma posted its September 2026 analyst and institutional investor meeting schedule, featuring Company Secretary Sampath Kumar Pallerlamudi and other key details. Read more
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.
